 | Up a level |
Journal Article
Gluz, Oleg, Nitz, Ulrike, Christgen, Matthias, Kuemmel, Sherko, Holtschmidt, Johannes, Priel, Jan, Hartkopf, Andreas, Potenberg, Jochem, Luedtke-Heckenkamp, Kerstin, Just, Marianne, Wuelfing, Pia, Von Schumann, Raquel, Graeser, Monika, Wuerstlein, Rachel, Kates, Ronald E., Kreipe, Hans Heinrich and Harbeck, Nadia (2020). De-escalated chemotherapy versus endocrine therapy plus pertuzumab plus trastuzumab for HR+/HER2+early breast cancer (BC): First efficacy results from the neoadjuvant WSG-TP-II study. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Malter, Wolfram, Eichler, Christian, Hanstein, Bettina, Mallmann, Peter and Holtschmidt, Johannes (2020). First Reported Use of Radiofrequency Identification (RFID) Technique for Targeted Excision of Suspicious Axillary Lymph Nodes in Early Stage Breast Cancer - Evaluation of Feasibility and Review of Current Recommendations. In Vivo, 34 (3). S. 1207 - 1214. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7549
Malter, Wolfram, Eichler, Christian, Puppe, Julian, Thangarajah, Fabishy, Mallmann, Peter, Krug, Barbara, Warm, Mathias and Holtschmidt, Johannes (2020). First reported use of the Faxitron LOCalizer (TM) Radiofrequency Identification (RFID) system in the axilla- A pilot trial in targeted axillary dissection (TAD). Cancer Res., 80 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Malter, Wolfram, Holtschmidt, Johannes, Thangarajah, Fabinshy, Mallmann, Peter, Krug, Barbara, Warm, Mathias and Eichler, Christian (2019). First Reported Use of the Faxitron LOCalizer (TM) Radiofrequency Identification (RFID) System in Europe - Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions. In Vivo, 33 (5). S. 1559 - 1565. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7549
Thangarajah, Fabinshy, Vogel, Constanze, Pahmeyer, Caroline, Eichler, Christian, Holtschmidt, Johannes, Ratiu, Dominik, Mallmann, Peter and Malter, Wolfram (2018). Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site. Anticancer Res., 38 (10). S. 6023 - 6027. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7530